Next meeting: Thursday, Oct. 22, and Friday, Oct. 23, 2020
The Texas Drug Utilization Review Board meets quarterly to develop criteria and standards impacting Texas Medicaid, including:
- Developing and submitting recommendations for the Texas Medicaid preferred drug list
- Suggesting clinical prior authorizations on outpatient prescription drugs.
- Recommending educational interventions for Medicaid providers.
- Reviewing drug utilization across the Medicaid program.
September 30, 2020
Registration Information for the Oct. DUR Board Meeting
September 29, 2020
Deadline extended: Drug Utilization Review Board Applications Due October 12
September 21, 2020
July 2020 Preferred Drug List Revised Sept. 17
September 18, 2020
Branded Concerta Tablets Return to Non-Preferred Status on Oct. 16
September 14, 2020
Two-day DUR Board Meeting Scheduled for Oct. 22 and 23
September 9, 2020
Insulin Products Return to Non-Preferred Status on Sept. 18
September 4, 2020
Epidiolex and Diacomit Clinical Prior Authorization Criteria Updates
August 11, 2020
July 2020 Drug Utilization Review Board Meeting Summary